1.Carnosic acid inhibits TLR4-MyD88 signaling pathway in LPS-stimulated 3T3-L1 adipocytes.
Mi Young PARK ; Seong Taek MUN
Nutrition Research and Practice 2014;8(5):516-520
BACKGROUND/OBJECTIVES: Carnosic acid (CA), found in rosemary (Rosemarinus officinalis) leaves, is known to exhibit anti-obesity and anti-inflammatory activities. However, whether its anti-inflammatory potency can contribute to the amelioration of obesity has not been elucidated. The aim of the current study was to investigate the effect of CA on Toll-like receptor 4 (TLR4) pathways in the presence of lipopolysaccharide (LPS) in 3T3-L1 adipocytes. MATERIALS/METHODS: 3T3-L1 adipocytes were treated with CA (0-20 microM) for 1 h, followed by treatment with LPS for 30 min; mRNA expression of adipokines and protein expression of TLR4-related molecules were then measured. RESULTS: LPS-stimulated 3T3-L1 adipocytes showed elevated mRNA expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and monocyte chemoattractant protein-1, and CA significantly inhibited the expression of these adipokine genes. LPS-induced up regulation of TLR4, myeloid differentiation factor 88, TNF receptor-associated factor 6, and nuclear factor-kappaB, as well as phosphorylated extracellular receptor-activated kinase were also suppressed by pre-treatment of 3T3-L1 adipocytes with CA. CONCLUSIONS: Results of this study suggest that CA directly inhibits TLR4-MyD88-dependent signaling pathways and decreases the inflammatory response in adipocytes.
Adipocytes*
;
Adipokines
;
Chemokine CCL2
;
Inflammation
;
Interleukin-6
;
Myeloid Differentiation Factor 88
;
Obesity
;
Phosphotransferases
;
RNA, Messenger
;
TNF Receptor-Associated Factor 6
;
Toll-Like Receptor 4
;
Tumor Necrosis Factor-alpha
;
Up-Regulation
2.Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice.
Mi Young PARK ; Seong Taek MUN
Nutrition Research and Practice 2013;7(4):294-301
In this study, we examined the hepatic anti-steatosis activity of carnosic acid (CA), a phenolic compound of rosemary (Rosmarinus officinalis) leaves, as well as its possible mechanism of action, in a high-fat diet (HFD)-fed mice model. Mice were fed a HFD, or a HFD supplemented with 0.01% (w/w) CA or 0.02% (w/w) CA, for a period of 12 weeks, after which changes in body weight, blood lipid profiles, and fatty acid mechanism markers were evaluated. The 0.02% (w/w) CA diet resulted in a marked decline in steatosis grade, as well as in homeostasis model assessment of insulin resistance (HOMA-IR) index values, intraperitoneal glucose tolerance test (IGTT) results, body weight gain, liver weight, and blood lipid levels (P < 0.05). The expression level of hepatic lipogenic genes, such as sterol regulating element binding protein-1c (SREBP-1c), liver-fatty acid binding protein (L-FABP), stearoyl-CoA desaturase 1 (SCD1), and fatty acid synthase (FAS), was significantly lower in mice fed 0.01% (w/w) CA and 0.02% (w/w) CA diets than that in the HFD group; on the other hand, the expression level of beta-oxidation-related genes, such as peroxisome proliferator-activated receptor alpha (PPAR-alpha), carnitine palmitoyltransferase 1 (CPT-1), and acyl-CoA oxidase (ACO), was higher in mice fed a 0.02% (w/w) CA diet, than that in the HFD group (P < 0.05). In addition, the hepatic content of palmitic acid (C16:0), palmitoleic acid (C16:1), and oleic acid (C18:1) was significantly lower in mice fed the 0.02% (w/w) CA diet than that in the HFD group (P < 0.05). These results suggest that orally administered CA suppressed HFD-induced hepatic steatosis and fatty liver-related metabolic disorders through decrease of de novo lipogenesis and fatty acid elongation and increase of fatty acid beta-oxidation in mice.
Acyl Coenzyme A
;
Acyl-CoA Oxidase
;
Animals
;
Body Weight
;
Carnitine O-Palmitoyltransferase
;
Carrier Proteins
;
Diet
;
Diet, High-Fat
;
Diterpenes, Abietane
;
Fatty Acid Synthetase Complex
;
Fatty Acids, Monounsaturated
;
Glucose Tolerance Test
;
Hand
;
Homeostasis
;
Insulin Resistance
;
Lipogenesis
;
Liver
;
Mice
;
Oleic Acid
;
Palmitic Acid
;
Phenol
;
Plant Extracts
;
PPAR alpha
;
Stearoyl-CoA Desaturase
3.Ruptured Tubal Pregnancy with Massive Retroperitoneal Hemorrhage.
Soonchunhyang Medical Science 2017;23(1):61-64
Ectopic pregnancy is an implantation of the fertilized ovum on a place except the endometrium. Most of the ectopic pregnancies are located at the fallopian tube. Few cases of retroperitoneal hematoma associated with ectopic pregnancy have been reported on previously; in each the retroperitoneal space had been the site of implantation. In contrast, we treated a patient with an ectopic pregnancy that implanted in the tube and then perforated through into the retroperitoneal space. To our knowledge this is very rare case of retroperitoneal hematoma caused by a ruptured tubal pregnancy.
Endometrium
;
Fallopian Tubes
;
Female
;
Hematoma
;
Hemorrhage*
;
Humans
;
Laparoscopy
;
Pregnancy
;
Pregnancy, Ectopic
;
Pregnancy, Tubal*
;
Retroperitoneal Space
;
Zygote
4.Struma Ovarii: A Case of Struma Ovarii and Literature Review.
Aeli RYU ; Seong Taek MUN ; Gaeul MOON ; Si Hyong JANG
Soonchunhyang Medical Science 2014;20(2):191-194
Struma ovarii is a rare, monodermal and highly specialized teratoma, composed entirely or predominantly (>50%) of thyroid tissue. Presenting symptoms are not specific. Despite containing thyroid tissue, only 5% of struma ovarii have features of hyperthyroidism. Therefore, preoperative diagnosis of struma ovarii is difficult. Recently, the authors experienced a case of struma ovarii found in a young woman who presented with known pelvic mass and dysmenorrhea. A transabdominal ultrasonography and computed tomography detected a 16-cm sized multiloculated mass in pelvic cavity. She underwent laparoscopic unilateral ovarian wedge resection. The final histopathologic diagnosis was struma ovarii of the mature cystic teratoma. Therefore, we report this rare case with a brief review of the literature.
Diagnosis
;
Dysmenorrhea
;
Female
;
Humans
;
Hyperthyroidism
;
Struma Ovarii*
;
Teratoma
;
Thyroid Gland
;
Ultrasonography
5.A Case of Mixed Small and Large Cell Neuroendocrine Carcinoma of the Uterine Cervix.
Aeli RYU ; Seong Taek MUN ; Shi Sun KIM
Soonchunhyang Medical Science 2014;20(2):108-111
A rare case of mixed carcinoma of the cervix is reported, composed of a small and large cell neuroendocrine carcinoma. Neuroendocrine cervical carcinomas are very rare and aggressive. The prognosis is very poor despite multimodal treatment. Earlier reports have shown that the majority of patients present with advanced stage disease, have lymph node metastasis, and are at a high risk for recurrence and disease progression. In this study, we report the case of a 26-year-old woman with composite small and large cell neuroendocrine carcinoma of the cervix. A woman presented with vaginal bleed since 2 months of presentation. Gynecologic examination revealed cervical enlargement, and punch biopsy of the cervical lesion was performed. The biopsy was disclosed a large cell neuroendocrine carcinoma. The patient underwent a radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymph node dissection. The final histopathologic findings are mixed small and large cell neuroendocrine carcinoma of cervix.
Adult
;
Biopsy
;
Carcinoma, Neuroendocrine*
;
Cervix Uteri*
;
Combined Modality Therapy
;
Disease Progression
;
Female
;
Humans
;
Hysterectomy
;
Lymph Node Excision
;
Lymph Nodes
;
Neoplasm Metastasis
;
Prognosis
;
Recurrence
;
Uterine Cervical Neoplasms
6.Primary malignant melanoma arising in a cystic teratoma.
Obstetrics & Gynecology Science 2013;56(3):201-204
The malignant transformation of a cystic teratoma is a rare event, occurring in about 0.2% to 1.8%. Primary malignant melanoma arising from the ovary is extremely rare. A primary melanoma in an ovarian cystic teratoma originates most frequently at the dermoepidermal junction, similar to a cutaneous melanoma. Though there are no standard adjuvant regimens for the treatment of primary malignant melanoma of the ovary. We present another case report of malignant melanoma developing in cystic teratoma.
Female
;
Melanoma
;
Ovarian Cysts
;
Ovary
;
Teratoma
7.A case of cesarean scar ectopic pregnancy.
Seong Taek MUN ; Yun Sook KIM ; Mi Yeong KIM ; Seob JEON ; Seung Do CHOI ; Jae Gun SUNWOO ; Dong Han BAE
Korean Journal of Obstetrics and Gynecology 2007;50(10):1432-1436
Cesarean scar pregnancy is one of the rarest forms of ectopic pregnancy. Little is known about its incidence and natural history. With increasing incidence of caesarean section worldwide, more and more cases are diagnosed and reported. Transvaginal ultrasound and colour flow Doppler provides a high diagnostic accuracy with very few false positives. A delay in diagnosis and/or treatment can lead to uterine rupture, major haemorrhage, hysterectomy and serious maternal morbidity. Surgical management can be safe and effective and medical treatment can be selected as appropriate selection criteria. Patients with history of a pregnancy in a cesarean delivery scar should be advised of the risk for future uterine rupture and placenta accreta. We experienced a case of ectopic pregnancy with treatment of surgical excision and report with a brief review of literatures.
Cesarean Section
;
Cicatrix*
;
Diagnosis
;
Female
;
Humans
;
Hysterectomy
;
Incidence
;
Natural History
;
Patient Selection
;
Placenta Accreta
;
Pregnancy
;
Pregnancy, Ectopic*
;
Ultrasonography
;
Uterine Rupture
8.Toremifene-associated endometrial polyp: A case report and review of the literature.
Eun Hee PARK ; Sung Yun BAHNG ; Tae Sung KIM ; Seong Taek MUN ; Jib Kwang CHUNG ; Seok Min LEE ; So Young JIN
Korean Journal of Obstetrics and Gynecology 2002;45(7):1214-1217
Antiestrogens have been widely used in the treatment of breast cancer patients. Although tamoxifen is one of the most prevalent antiestrogens, some reported its hepatocarcinogenic effects and the long-term treatment may increase the risk of endometrial and gastrointestinal cancer. Toremifene is an interesting new antiestrogen and have a similar antitumor efficacy as tamoxifen, with less side-effect including less uterotrophic effect compared to tamoxifen, in mice. we report a case of endometrial polyp which were associated with toremifene use, in postmenopausal woman with breast cancer, with a brief review of literature.
Animals
;
Breast Neoplasms
;
Estrogen Receptor Modulators
;
Female
;
Gastrointestinal Neoplasms
;
Humans
;
Mice
;
Polyps*
;
Tamoxifen
;
Toremifene
9.A Case of Normal Vaginal Delivery in the Pregnant Woman after Treatment of Pulmonary Edema During Dextran Therapy of the Sudden Deafness.
Seong Taek MUN ; Hae Hyeog LEE ; Tae Hee KIM ; Do Hyeoung KOO ; Kwon Hae LEE ; Yil Ku SHIM ; Kye Hyun NAM ; Sang Heon CHA ; In Sook CHO ; Im Soon LEE
Korean Journal of Obstetrics and Gynecology 2003;46(10):2088-2091
Dextran of a low molecular weight (dextran 40) is frequently used to improve regional perfusion after surgery in spite of the potentially serious complications such as noncardiogenic pulmonary edema, oliguric renal failure, and coagulopathy that have been widely reported. Dextran is used to improve cochlear microcirculation in sudden deafness of vascular origin, but the frequency of complications is rarely reported in the field of otolaryngology. We reviewed the literature of a case we experienced in which a pregnant woman, after recovering from pulmonary edema caused by treatment for sudden deafness with dextran, had a successful vaginal delivery.
Dextrans*
;
Female
;
Hearing Loss, Sudden*
;
Humans
;
Microcirculation
;
Molecular Weight
;
Otolaryngology
;
Perfusion
;
Pregnant Women*
;
Pulmonary Edema*
;
Renal Insufficiency
10.The indications, effectiveness and complications of the selective arterial embolization in the management of obstetrical hemorrhage.
Bo ra PARK ; Na Hye LEE ; Yun Sook KIM ; Seong Taek MUN ; Jae Gun SUNWOO ; Dong han BAE ; Chae Hun GANG
Korean Journal of Perinatology 2009;20(1):36-43
PURPOSE:The objective of this study was to evaluate the indications, effectiveness and complications associated with uterine arterial embolization as an alternative treatment of obstetrical hemorrhage. METHODS:From January 2006 to December 2008, 25 patients who underwent angiographic embolization for the obstetrical hemorrhage that was not responsive to conventional treatments, like obstetric maneuvers and uterotonic drugs, were included in our study. All medical records were reviewed and detailed clinical data such as clinical status, underlying conditions, amount of transfusion, embolized arteries, hospital stay, the success rate and the complications were collected. RESULTS:We have experienced clinically successful embolization in 22 (88%) of 25 patients with obstetrical hemorrhage resulting from various causes. After embolization, the patients' vital signs were stabilized. The causes of hemorrhage were atony of uterus (n=10), myomectomy during cesarean section (n=6), abnormal placentation (n=5), arterio-venous malformation (n=3), and cervical pregnancy (n=1). The average amount of blood transfusion was 7.2 units (range; 0~39 units). The average length of the time for the procedure was 55 minutes (range: 25~96 minutes). The average duration of hospitalization was 5.5 days (range: 2~14 days). In 22 patients, menses resumed spontaneously after procedures. The main complications after embolization were numbness and pain on lower extremities (n=1), and hypomenorrhea (n=1). CONCLUSION:The atrerial embolization is one of the safe and effective procedures that offers patients an alternative to hysterectomy for the treatment of intractable postpartum hemorrhage.
Arteries
;
Blood Transfusion
;
Cesarean Section
;
Female
;
Hemorrhage
;
Hospitalization
;
Humans
;
Hypesthesia
;
Hysterectomy
;
Length of Stay
;
Lower Extremity
;
Medical Records
;
Menstruation Disturbances
;
Placentation
;
Postpartum Period
;
Pregnancy
;
Uterus
;
Vital Signs